Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Jun;24(1-2):189-95.
doi: 10.1007/BF01968100.

Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats

Affiliations

Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats

M Taira et al. Agents Actions. 1988 Jun.

Abstract

Possible chemical mediators contributing to 48 hour passive cutaneous anaphylaxis (PCA) in rats were investigated. Forty-eight hour PCA was inhibited considerably by mepyramine and methysergide given intravenously, a finding suggestive of a major role for histamine and serotonin in the reaction. AA-861, a selective 5-lipoxygenase inhibitor did not inhibit the PCA, and leukotriene (LT)D4 or LTE4 and the combination with prostaglandin (PG)E2 had no significant skin reaction. In addition, only small amounts of slow reacting substance of anaphylaxis (SRS-A) were detected in skin fragments, in vitro. Although CV-3988, a selective platelet activating factor (PAF) antagonist, dose-dependently inhibited the PAF-induced skin reaction, the PCA was not affected by treatment with this compound. Indomethacin also had no inhibitory activity on PCA. Thus, sulfidopeptide LTs, PAF and arachidonate cyclooxygenase metabolites probably do not contribute to PCA, at least in rats.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Prostaglandins. 1981 Apr;21(4):637-48 - PubMed
    1. Int Arch Allergy Appl Immunol. 1974;47(5):633-49 - PubMed
    1. J Chromatogr. 1980 Dec 12;221(2):265-70 - PubMed
    1. Lab Invest. 1985 Jun;52(6):617-30 - PubMed
    1. J Immunol. 1980 Aug;125(2):946-55 - PubMed